News
The sound of rain may feel romantic to some, but for parents? It’s a seasonal alarm bell. Not just puddles and power cuts, an annual wave of infections that hit kids the hardest.
For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
The ACIP is recommending the use of Enflonsia for the prevention of RSV lower respiratory tract disease in infants younger than 8 months.
2d
News-Medical.Net on MSNHow underreporting masks the real impact of RSV in older populationsResearch shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results